secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2023-03-28T23:59:59+00:00
Accession:  0001193125-23-082305
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics director Philip Low resigns from Board
----------------------------------------------------------

- Director Philip Low, Ph.D. resigned from the Board effective March 27, 2023.
- Departure was not a result of any disagreement with the Company, Board, or management.
- No replacement has been announced for the vacant Board seat.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312523082305/0001193125-23-082305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312523082305/d365921d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-082305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer